SMTL ID : 5id0.1 (1 other biounit)

Cetuximab Fab in complex with aminoheptanoic acid-linked meditope

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.48 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 4 residues within 4Å: Chain B: R.38, S.40, K.43, N.88 7 PLIP interactions: 7 interactions with chain B Hydrophobic interactions: B:K.43 Hydrogen bonds: B:K.43, B:K.43 Water bridges: B:R.38, B:R.38, B:E.46, B:N.88

2 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.2: 5 residues within 4Å: Chain A: T.164, E.165, D.167 Chain B: V.169, H.170 5 PLIP interactions: 3 interactions with chain A, 2 interactions with chain B Water bridges: A:T.164, A:T.164, A:S.168 Hydrogen bonds: B:V.169 Salt bridges: B:H.170 PO4.3: 4 residues within 4Å: Chain B: N.205, K.207, N.210, K.212 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:N.205, B:N.210

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bzymek, K.P. et al., Cyclization strategies of meditopes: affinity and diffraction studies of meditope-Fab complexes. Acta Crystallogr F Struct Biol Commun (2016)

Release Date

2016-06-15

Peptides

Cetuximab Fab light chain: A
Cetuximab Fab heavy chain: B
Cyclic meditope: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
E

Cetuximab Fab light chain

Cetuximab Fab heavy chain

Cyclic meditope

Related Entries With Identical Sequence